Equity
Total Equity
Medtronic Total Equity increased by 0.7% to $48.99B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 0.8%, from $49.39B to $48.99B. Over 4 years (FY 2021 to FY 2025), Total Equity shows relatively stable performance with a -1.7% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementBalance Sheet Statement
SectionEquity
CategoryCapital Allocation
SignalHigher is better
VolatilityStable
First reportedQ4 2013
Last reportedQ3 2026Feb 24, 2026
How to read this metric
A growing equity base generally signals long-term value creation and financial health.
Detailed definition
Total stockholders' equity represents the residual interest in the assets of the company after deducting all liabilities...
Peer comparison
Used to calculate Return on Equity (ROE) and compare against industry peers.
Metric ID:
total_stockholders_equityHistorical Data
20 periods
| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $51.43B | $51.49B | $51.99B | $52.54B | $52.55B | $52.67B | $51.88B | $51.44B | $51.48B | $51.18B | $51.46B | $51.79B | $50.21B | $47.95B | $48.49B | $49.39B | $48.02B | $47.89B | $48.65B | $48.99B |
| QoQ Change | — | +0.1% | +1.0% | +1.1% | +0.0% | +0.2% | -1.5% | -0.8% | +0.1% | -0.6% | +0.6% | +0.6% | -3.0% | -4.5% | +1.1% | +1.8% | -2.8% | -0.3% | +1.6% | +0.7% |
| YoY Change | — | — | — | — | +2.2% | +2.3% | -0.2% | -2.1% | -2.0% | -2.8% | -0.8% | +0.7% | -2.5% | -6.3% | -5.8% | -4.6% | -4.4% | -0.1% | +0.3% | -0.8% |
Range$47.89B – $52.67B
CAGR-1.0%
Avg YoY Growth-1.7%
Median YoY Growth-1.4%
Current Streak2 quarters growth
Total Equity at Other Companies
Frequently Asked Questions
- What is Medtronic's total equity?
- Medtronic (MDT) reported total equity of $48.99B in Q4 2025.
- How has Medtronic's total equity changed year-over-year?
- Medtronic's total equity decreased by 0.8% year-over-year, from $49.39B to $48.99B.
- What is the long-term trend for Medtronic's total equity?
- Over 4 years (2021 to 2025), Medtronic's total equity has grown at a -1.7% compound annual growth rate (CAGR), from $51.43B to $48.02B.
- What does total equity mean?
- The total value of the company belonging to shareholders after all debts are paid.